Characterization of tumor response with lenvatinib plus pembrolizumab in study 309/KEYNOTE-775 Meeting Abstract


Authors: Makker, V.; Lorusso, D.; Moore, R.; Miller, D.; Mackay, H.; Santin, A.; Ushijima, K.; Kim, Y. M.; Sanli, U.; Yonemori, K.; Xie, R.; Barresi, G.; McKenzie, J.; Colombo, N.
Abstract Title: Characterization of tumor response with lenvatinib plus pembrolizumab in study 309/KEYNOTE-775
Meeting Title: Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women’s Cancer (54th Annual Meeting)
Journal Title: Gynecologic Oncology
Volume: 176
Issue: Suppl. 1
Meeting Dates: 2023 Mar 25-28
Meeting Location: Tampa, FL
ISSN: 0090-8258
Publisher: Elsevier Inc.  
Date Published: 2023-09-01
Start Page: S68
End Page: S69
Language: English
ACCESSION: WOS:001079556100099
DOI: 10.1016/j.ygyno.2023.06.563
PROVIDER: wos
Notes: Meeting Abstract: 177 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Vicky Makker
    263 Makker